Official Visit to Brussels, Belgium - 11 -12 Nov 2015

IAEA Director General Yukiya  Amano tours the offices of IBA, a high technology medical company in Brussels specializing in proton therapy, radiopharmacy, particle accelerators and dosimetry, on 12 November 2015 during his official visit to Belgium. IAEA Director General Yukiya  Amano tours the offices of IBA, a high technology medical company in Brussels specializing in proton therapy, radiopharmacy, particle accelerators and dosimetry, on 12 November 2015 during his official visit to Belgium. IAEA Director General Yukiya  Amano tours the offices of IBA, a high technology medical company in Brussels specializing in proton therapy, radiopharmacy, particle accelerators and dosimetry, on 12 November 2015 during his official visit to Belgium. IAEA Director General Yukiya  Amano tours the offices of IBA, a high technology medical company in Brussels specializing in proton therapy, radiopharmacy, particle accelerators and dosimetry, on 12 November 2015 during his official visit to Belgium. IAEA Director General Yukiya  Amano tours the offices of IBA, a high technology medical company in Brussels specializing in proton therapy, radiopharmacy, particle accelerators and dosimetry, on 12 November 2015 during his official visit to Belgium. IAEA Director General Yukiya  Amano tours the offices of IBA, a high technology medical company in Brussels specializing in proton therapy, radiopharmacy, particle accelerators and dosimetry, on 12 November 2015 during his official visit to Belgium. IAEA Director General Yukiya  Amano tours the offices of IBA, a high technology medical company in Brussels specializing in proton therapy, radiopharmacy, particle accelerators and dosimetry, on 12 November 2015 during his official visit to Belgium. IAEA Director General Yukiya  Amano together with the staff of IBA on 12 November 2015 during his official visit to Belgium.
Last update: 30/11/2015

Síganos

Hoja informativa